Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
UVM Health Lays Off Staff at New York Hospitals
University of Vermont Health eliminated nine positions on April 14 at two New York hospitals—two at Alice Hyde Medical Center in Malone and seven at Champlain Valley Physicians Hospital in Plattsburgh. The layoffs are part of a broader effort to control rising operating costs and adapt to shifting health‑policy environments. UVM Health, a rural academic system serving Vermont and northern New York, employs more than 14,000 staff. The cuts underscore the financial tightrope faced by providers in sparsely populated regions.
BMC South Workers Rescind Strike Notice
More than 475 registered nurses and healthcare workers at BMC South in Brockton rescinded a three‑day strike notice originally set for April 30 after progress was made in contract talks. The Massachusetts Nurses Association said the union will hold off on...
Cottage Health Formalizes Innovation with New Leadership Role
Cottage Health in Santa Barbara has created its first chief innovation officer role, appointing Dr. Ryan Kelly to lead the Compton Center for Medical Excellence and Innovation. The new office will formalize idea intake, evaluation and decision‑making processes, aiming for...
FDA Identifies Recall of Catheter Kits, Early Alert for Sterile Labels
The FDA announced a nationwide recall of Arrow International dialysis catheter kits that contain Merit Medical 16F Dual‑Valved Splittable Sheath Introducers because the sheath may not split as designed. Simultaneously, the agency issued an Early Alert for Omnicell i.v.STATION sterile...
UnitedHealth Completes Sale of UK Business to TPG
TPG has completed the acquisition of Optum UK, UnitedHealth Group’s subsidiary that owns EMIS Group, the software platform powering most NHS electronic patient records. The transaction, closed on March 13, was valued between £1.2 billion and £1.4 billion (approximately $1.5‑$1.8 billion). UnitedHealth reported $400 million...
Blog: (Re)Designing Care Delivery and Operating Models for the Future at the AHA Leadership Summit
The American Hospital Association’s 2025 Leadership Summit convened senior health‑care executives, clinicians, and innovators in Denver from July 12‑14, spotlighting new care‑delivery and operating‑model strategies. Key sessions examined AI‑enabled patient experiences, value‑based reimbursement, and integrated health networks. The AHA Board elected...
SBIA Resources in Chinese 中文信息
The FDA’s Small Business and Industry Assistance (SBIA) program has released Chinese-language versions of six recent webinars, covering critical topics such as the Drug Supply Chain Security Act, establishment registration, electronic submission requirements, eCTD data standards, GDUFA II, and generic drug...
HIMSS26 Changemaker Advocates for Health IT Causes
At HIMSS26, federal lobbyist Brett Meeks of Jeffrey J. Kimbell & Associates highlighted his daily mission to advance health‑IT interoperability and data privacy. Speaking as a Changemaker, Meeks emphasized the urgency of unified data standards as AI becomes embedded in...
Bridging the Gap in Neurodevelopmental Care and Pediatrics
Dr. Ronald L. Lindsay reflects on decades of effort to connect developmental‑behavioral pediatrics with neurodevelopmental disability services, noting both successes—such as the LEND program, JBLM‑CARES, and the NIMH‑RUPP Autism Network expansion—and persistent institutional resistance. He explains that many bridges collapsed...
Medicaid Administrative Burden Hits Providers
A Gainwell Technologies survey of 309 Medicaid providers reveals that 28% are dissatisfied with administrative processes, making them 3.9 times more likely to leave the program within three years. Dissatisfaction is driving a quarter of skilled nursing facilities, physician groups...
ERAS-0015 Linked to Fatal Pneumonitis After Care Withdrawal
$ERAS safety update, from tonight's slides. One Grade 3 TRAE of pneumonitis progressed to Grade 5 after withdrawal of supportive care per patient decision. The patient was a 66 year-old male with heavily pretreated metastatic pancreatic adenocarcinoma who received 24 mg of ERAS-0015. The patient had...
FDA Grants Breakthrough Designation for Efimosfermin for MASH
GSK’s investigational liver drug efimosfermin received FDA breakthrough therapy designation for metabolic dysfunction‑associated steatohepatitis (MASH). A phase‑2 trial showed 45.2% of patients achieved at least one‑stage fibrosis improvement versus 20.6% on placebo, and 67.7% attained MASH resolution compared with 29.4%...
French Health Agency Unveils Concrete Toolkit to Tackle Workplace Psychosocial Risks
France's national health insurer, Assurance Maladie, published a set of practical solutions on April 27, 2026 to help employers identify and prevent psychosocial risks. The package includes ready‑to‑use questionnaires, risk‑assessment grids and a framework for external consultant support, aiming to embed mental‑well‑being into...
Gluten Triggers Immune Response at 3 Mg, Below Current Labeling Limits
Researchers in Australia demonstrated that a single gluten dose as low as 3 mg provokes measurable immune activation in celiac disease patients, well under the 20 ppm threshold used for gluten‑free labeling. The finding raises questions about the adequacy of current safety...
Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast
QT Imaging introduced a 3‑D ultrasound breast‑cancer screening tool that eliminates compression, radiation, and contrast agents. Early head‑to‑head trials with Mayo Clinic suggest detection rates comparable to MRI while potentially reducing unnecessary biopsies. The scanner automatically measures breast density and...
Registration Is Open for the American Diabetes Association’s 2026 Camps
Registration is now open for the American Diabetes Association’s 2026 camp season, which will host more than 40 camps in 28 states. The program serves children, teens and adults living with diabetes, offering weekend or week‑long day and overnight sessions...
FDA Grants Accelerated Approval to Regeneron's Otarmeni Gene Therapy for Genetic Hearing Loss
The U.S. FDA has granted accelerated approval to Regeneron Pharmaceuticals’ Otarmeni (lunsotogene parvec‑cwha), the first in‑vivo gene therapy for OTOF‑related sensorineural hearing loss. The decision, based on a 20‑patient CHORD trial, makes the treatment free for U.S. patients and expands...
A Political History of Australian Health Policy, Part 2: Health in Hard Times, 1934-1943
The article examines how Australia’s health policy transformed between 1934 and 1943 as the Great Depression and World War II reframed sickness from a public‑health issue to a socioeconomic risk. Election rhetoric during this period increasingly portrayed illness as a threat...
NIH Studies Often Ignore Sex Differences, Hindering Precision Medicine
Less than half of NIH-funded health studies analyze results by sex, potentially overlooking critical differences that impact diagnosis, treatment, and drug development for both men and women. precisionmedicine
TytoCare Gets FDA De Novo Clearance for First AI Eardrum Diagnostic Tool
TytoCare announced FDA De Novo classification for its Tyto Insights™ for ENT Suite, the first AI-driven eardrum analysis device. The clearance creates a new regulatory category for AI ENT image analyzers and positions the company to address 20 million annual pediatric...
CRP: What It Can, and Can't, Tell You
High‑sensitivity C‑reactive protein (hsCRP) is an inflammation marker used to refine cardiovascular risk assessment. The 2025 ACC scientific statement recommends a one‑time baseline hsCRP measurement, with values 3 mg/L high risk. Clinical trials such as JUPITER demonstrated that statin therapy reduces...
Pharma R&D Embraces Data Lakehouses, Boosting Speed and Cutting Costs
AstraZeneca, Illumina and Pfizer are moving their research data onto lakehouse platforms such as Databricks, Snowflake and Apache Iceberg. Pfizer reports a four‑fold query speed increase and a 57% reduction in total cost of ownership, signaling a sector‑wide shift toward...
Sona Nanotech Reports 60% Complete Response Rate in First‑Human Melanoma Trial
Sona Nanotech Inc. presented first‑in‑human data showing six complete responses out of ten late‑stage melanoma patients at the AACR meeting in San Diego and secured a slot at the upcoming ASCO conference. The results, derived from the company’s gold‑nanorod Targeted...
Steam Trap Surveys Boost Hospital Efficiency, Safety
American Plant Maintenance (APM Steam) conducted a comprehensive steam‑trap survey across Northwell Health’s hospital network, inspecting 9,817 traps. The audit uncovered over $2.4 million in gas and electric savings, 946,500 natural‑gas therms conserved, and nearly $1.2 million in utility incentives. A detailed...
STAT+: Erasca Touts Strong, Though Preliminary, Results in Trial of Pancreatic and Lung Cancer Therapy
Erasca announced that its oral RAS‑targeting drug ERAS‑0015 produced tumor shrinkage in 40% of patients with advanced pancreatic cancer and 62% of those with advanced non‑small‑cell lung cancer. The early‑stage data, gathered from trials in the United States and China,...
Former Senator Ben Sasse Credits Experimental Cancer Drug for Extending Life
Former Nebraska senator Ben Sasse, battling terminal pancreatic cancer, says an experimental drug has given him additional months of life. The interview highlights the promise and uncertainty of cutting‑edge oncology treatments and fuels discussion about patient access to novel therapies.
Health Systems Can Get Started With Microsoft Dragon Copilot Today to Improve Clinical Workflows
Microsoft’s Dragon Copilot, an AI‑driven clinical assistant, is now generally available for health systems. The platform automates documentation, pulls data from electronic health records, and offers role‑specific workflows for physicians, nurses and radiologists. More than 100,000 clinicians have adopted the...
A Treatment for Pre-Eclampsia May Be on the Horizon
Researchers have unveiled a blood‑filtering therapy that shows promise in treating pre‑eclampsia, a life‑threatening pregnancy complication. Early‑stage trials reported significant reductions in maternal blood pressure and improved organ function without harming the fetus. The approach works by extracorporeally removing circulating...
Federal Circuit Clarifies Written Description and Enablement Standards for Method-of-Treatment Patent Claims Using a Well-Known Antibody Genus
On April 16, 2026, the Federal Circuit reversed a district‑court ruling and held that Teva’s method‑of‑treatment patents for treating headache with anti‑CGRP antagonist antibodies met the written‑description and enablement requirements of 35 U.S.C. § 112. The court distinguished the Supreme Court’s Amgen decision,...
Large Study Looks At Benefits Of Doula Care On Postpartum Outcomes
A new JAMA Network Open meta‑analysis of 22 studies confirms that birth doulas lower maternal anxiety, boost early breastfeeding rates, and improve postpartum follow‑up, though they do not significantly affect cesarean rates or labor pain. Medicaid coverage for doula services...
(Re)Designing Care Delivery and Operating Models for the Future at the AHA Leadership Summit
The American Hospital Association’s Leadership Summit will convene July 12‑14 in Denver, gathering more than 125 speakers from over 60 hospitals and health systems. The three‑day program tackles the most pressing challenges in health care, including value‑based care, workforce redesign, AI,...
FY 2027 IPPS/LTCH PPS Proposed Rule Summary
On April 10, 2026 CMS issued a proposed rule outlining FY 2027 payment rates and policies for Medicare’s inpatient prospective payment system (IPPS) and long‑term care hospital (LTCH) PPS, with a public comment deadline of June 9, 2026. The rule sets operating and...
Boston Scientific Pacemakers Recalled Again—Software Update Now Available
The FDA issued a Class I recall affecting more than 1.4 million Boston Scientific pacemakers after reports that a battery‑related flaw could force devices into a permanent safety mode, resulting in over 800 injuries and two deaths. Boston Scientific has released a...
Nervonik Announces $52.5M Series B Financing
Nervonik, a clinical‑stage medical‑device firm focused on peripheral nerve stimulation, announced the close of a $52.5 million Series B round. The financing was led by Amzak Health and attracted participation from Elevage Medical Technologies, U.S. Venture Partners, Lumira Ventures, Foothill Ventures, and...
Early Detection of Bowel Cancer in the UK Represents Success of Screening Program
The UK’s bowel‑cancer screening programme, launched in 2006, is delivering measurable gains. NHS data show 7 million people screened in 2025, up from 4.7 million in 2015, and 70,000 cancers detected among 85 million tests. The rollout of home‑based faecal immunochemical kits and...
Medtronic Reports Data Breach on Corporate IT Systems
Medtronic disclosed an unauthorized access to its corporate IT systems but said the breach did not affect product, manufacturing or patient‑care networks. The company activated its incident‑response plan, engaged external cybersecurity experts, and is reviewing whether personal data was exposed....
Rare Cancer Patients Demand Systemic Oncology Revolution
Merkel cell carcinoma log, day #637. I’m participating in the 4th annual Merkel cell carcinoma conference (MCC4) in Boston today. Most of the top people in the field are here. Had a roundtable conversation with a group of patients and...
CDC Shifts From Public Health to Industry Lobbyists
2025: get rid of tobacco and environmental health offices at CDC. 2026: hire more oil and tobacco lobbyists to run CDC
Overcoming Barriers to Holding Babies with Hypoxic-Ischemic Encephalopathy During Therapeutic Cooling
Therapeutic hypothermia remains the standard treatment for newborns with hypoxic‑ischemic encephalopathy (HIE), but most NICUs prohibit parental holding during the 72‑hour cooling period. Recent, albeit small, studies show that holding does not cause temperature instability or vital‑sign changes, yet an...
Over Half of Gray Market Peptides Fail Quality Standards
New pre-print on gray market peptides using @finnrick_tests data: 41.6% to 71.1% of gray market peptide samples failed to meet basic quality criteria, and measurable endotoxin contamination was present in 15% of samples. @Krysia830073
Low Post‑Surgery Klotho Predicts Inflammation and Cognitive Decline
Lower levels of the anti-aging protein Klotho after surgery were strongly linked to higher inflammation and worse cognitive function in patients with postoperative cognitive dysfunction (POCD). This suggests Klotho could be a useful early biomarker—and possibly a treatment target—for predicting...
Court Rejects Wrongful Termination Claim Against UC Health After HIPAA Report
An Ohio appellate court affirmed UC Health's decision to fire social worker Danielle Drake after she accessed a patient’s protected health information to report a suspected HIPAA breach. The court found the employer had a legitimate business justification, noting Drake’s...
Erasca Shows Promising 40% PDAC, 62% NSCLC Responses
$ERAS Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy $RVMD 40% uORR in PDAC; 62% uORR in NSCLC https://t.co/90BkD7tBeN
Longevity Hype Outpaces Evidence; Cancer Risk Remains
This @NYTmag article on longevity science, reversing aging with cellular reprogramming, by @susandominus, is over the top. We have no proof that rejuvenation of a human organ is possible, no less the whole body, and there is risk of inducing...
DeviceTalks Minnesota 2026 Show Preview: Speakers, Exhibitors and More
DeviceTalks Minnesota will convene on May 4, 2026 at the University of Minnesota’s McNamara Alumni Center. The agenda features keynotes from Abbott’s Lisa Earnhardt, Solventum’s Heather Knight, HistoSonics’ Mike Blue and Medical 21’s Manny Villafaña, plus panels of med‑tech OEMs. Exhibitors such as...
Harvard Med Mission Revision Deemed
Pleased to have the opportunity to share my perspective w @thecrimson on the revised @harvardmed mission statement, an update I thought was eminently reasonable. https://t.co/AQFC5AZd6p My full quote below; sentences 2 & 3 used in story. @zakkohane https://t.co/m8TQTzMqYZ
Kennedy Misses Deadline, Fuels Transparency Concerns
Kennedy missed a Friday deadline to release details of an HHS contract with a longtime vaccine critic. Democratic lawmakers say it’s part of a larger pattern of the secretary ignoring his promises of “radical transparency” https://t.co/ICAsieVw9Y
Cearvol Nano OTC Hearing Aids Boost Volume Everywhere
Wish you could hear everything around you, whether you're at a noisy restaurant or just watching TV at home? I check out the Cearvol Nano OTC Hearing Aids in various locations and find it's a great way to turn up...
AI Enables Radiology to Shift From Diagnosis to Prediction
Radiology is moving from reactive diagnosis to predictive care. Karim Karti shares how AI can help radiologists practice at the top of their license and unlock earlier disease detection. Watch the full interview here: https://t.co/tyyTn5ZWEx @RapidAI #MedicalImagingAI #HITSM https://t.co/P8qvua7WsD
Reta Won't Become All-Time Top-Selling Drug
Reta will not be the best selling drug of all time. Someone please remember this a decade from now.